HSBC downgraded shares of Repsol (OTCMKTS:REPYY – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Tuesday, The Fly reports.
A number of other analysts also recently issued reports on the company. JPMorgan Chase & Co. assumed coverage on Repsol in a report on Wednesday, April 19th. They set an underweight rating for the company. Morgan Stanley cut Repsol from an overweight rating to an equal weight rating in a research report on Tuesday, April 18th. Jefferies Financial Group cut Repsol from a buy rating to a hold rating in a research report on Wednesday, May 17th. Finally, BNP Paribas cut Repsol from an outperform rating to a neutral rating in a research report on Tuesday, April 4th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Repsol currently has an average rating of Hold and an average price target of $16.00.
Repsol Stock Down 0.8 %
Shares of OTCMKTS REPYY opened at $14.29 on Tuesday. The company has a market capitalization of $18.97 billion, a price-to-earnings ratio of 4.78, a price-to-earnings-growth ratio of 0.46 and a beta of 0.76. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.55 and a quick ratio of 1.12. The business has a 50-day moving average of $14.83 and a two-hundred day moving average of $15.32. Repsol has a 1 year low of $10.79 and a 1 year high of $17.31.
Repsol SA is engaged in the exploration and production of crude oil, natural gas, and refined petroleum. It operates through the following business segments: Upstream, Downstream, and Corporation & Others. The Upstream segment engages in exploration and development of crude oil and natural gas reserves.
- Get a free copy of the StockNews.com research report on Repsol (REPYY)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Repsol Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repsol and related companies with MarketBeat.com's FREE daily email newsletter.